PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours

by McKeage Mark J, Jameson Michael B, Ramanathan Ramesh K, Rajendran Joseph, Gu Yongchuan, Wilson William R, Melink Teresa J, Tchekmedyian N
Published 2012-10-01